Biotech company Orbis Diagnostics this morning announced it has teamed up with Green Cross Health, which owns Unichem and Life pharmacies, to trial its Covid immunity testing device.
Biotech company Orbis Diagnostics this morning announced it has teamed up with Green Cross Health, which owns Unichem and Life pharmacies, to trial its Covid immunity testing device.
Orbis' device can quickly and accurately measure a person's antibody concentration as a result of vaccination. Knowing your risk of infection could be useful when weighing up decisions such as whether to book overseas travel or to visit elderly relatives, says CEO Damian Camp.
Orbis' device can quickly and accurately measure a person's antibody concentration as a result of vaccination. Knowing your risk of infection could be useful when weighing up decisions such as whether to book overseas travel or to visit elderly relatives, says CEO Damian Camp.
How do I judge my risk of getting Covid? A strategic agreement between Green Cross Health, owner of the Unichem and Life Pharmacy brands, and Auckland-based research company Orbis Diagnostics looks like making that possible.
How do I judge my risk of getting Covid? A strategic agreement between Green Cross Health, owner of the Unichem and Life Pharmacy brands, and Auckland-based research company Orbis Diagnostics looks like making that possible.
"This move by the FDA reflects the global demand for technology that helps to ensure vaccination and booster programmes are effective." says Damian Camp, Orbis Diagnostics' Chief Executive.
"This move by the FDA reflects the global demand for technology that helps to ensure vaccination and booster programmes are effective." says Damian Camp, Orbis Diagnostics' Chief Executive.
The Orbis Immunity test is one of the solutions Sir Ian Taylor is trialling in his trip to America. It's a game-changer, he says, to have confirmation that his vaccination is providing him protection against the virus.
The Orbis Immunity test is one of the solutions Sir Ian Taylor is trialling in his trip to America. It's a game-changer, he says, to have confirmation that his vaccination is providing him protection against the virus.
Just hours before leaving for the US, Sir Ian Taylor had his COVID-19 immunity level measured by Orbis Diagnostics. The technology will be important to determine when booster shots are needed, he said.
Just hours before leaving for the US, Sir Ian Taylor had his COVID-19 immunity level measured by Orbis Diagnostics. The technology will be important to determine when booster shots are needed, he said.
_landing.jpg)
%20(1).png)
